摘要
他达拉非——长效5型磷酸二酯酶(PDE5)抑制剂是治疗勃起功能障碍(ED)的首选药物之一。许多临床研究证实其在普通ED患者、老年患者以及伴有糖尿病、脊髓损伤或前列腺癌术后患者中有较好的疗效和良好的安全性及耐受性,而且其独特的长达36 h的时间窗不仅增强了患者的自信心,更改善了患者及其伴侣的生活质量。
As a long-acting phosphodiesterase type 5（PDE5） inhibitor,tadalafil is administered orally as the first line therapy for erectile dysfunction（ED）.Its efficacy and safety have been confirmed by many clinical studies in the treatment of ED in general patients,elderly patients and those with diabetes mellitus or spinal cord injury or after prostate cancer surgery.With its prolonged action of 36 hours,tadalafil can not only increase the self-esteem of ED men but also improve the quality of life of both the patients and their partners.
出处
《中华男科学杂志》
CAS
CSCD
北大核心
2009年第10期956-959,共4页
National Journal of Andrology
